U.S. health officials have approved a new weight-loss pill from Eli Lilly. The Food and Drug Administration's decision Wednesday means patients in the United States will soon have access to a second daily oral medication to treat obesity and weight-related issues. The drug will be sold as Foundayo and it's expected to begin shipping Monday. Lilly says pricing for people with insurance will start as low as $25 per month. The new pill joins Novo Nordisk’s oral Wegovy pill, which has generated more than 600,000 prescriptions in the U.S. since its approval in December.